Company Filing History:
1 out of 1,863 
1 out of 597 
Years Active: 2023
Title: The Innovative Contributions of Hongying Cheng
Introduction
Hongying Cheng is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of medical research, particularly in the treatment of COVID-19 infections. His innovative approach has garnered attention in the scientific community.
Latest Patents
Hongying Cheng holds a patent for "Compositions and methods for treating a COVID-19 infection." This patent outlines methods of treating COVID-19 by administering an effective amount of a composition that reduces the superantigen character of the SARS-CoV-2 Spike protein. The compositions include mimetic peptides of the superantigen region and humanized antibodies, such as humanized mAb 6D3, that bind to the superantigen region. He has 1 patent to his name.
Career Highlights
Throughout his career, Cheng has worked with prestigious institutions, including the University of Pittsburgh and Cedars-Sinai Medical Center. His work has focused on developing innovative treatments that address critical health challenges.
Collaborations
Cheng has collaborated with esteemed colleagues, including Ivet Bahar and She Zhang, who have contributed to his research endeavors. Their combined expertise has enhanced the impact of his work in the medical field.
Conclusion
Hongying Cheng's contributions to the treatment of COVID-19 highlight his innovative spirit and dedication to advancing medical science. His work continues to inspire future research and development in the field.